| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.004 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.004 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |